Bacillus Calmette-Guerin (BCG) enhances monocyte- and lymphocyte-mediated bladder tumour cell killing

Intracavitary Bacillus Calmette-Guerin in the Treatment of Superficial Bladder Tumors

Álvaro Morales, David Eidinger, Andrew W. Bruce · The Journal of Urology · 2016 · 1.5K citations

Medicine, Oncology, Urology +5

Incidence and Treatment of Complications of Bacillus Calmette-Guerin Intravesical Therapy in Superficial Bladder Cancer

Donald L. Lamm, A.P.M. van der Meijden, Álvaro Morales et al. · The Journal of Urology · 1992 · 795 citations

Medicine, Oncology, Urology +8

Requirement of a Thymus Dependent Immune Response for Bcg-mediated Antitumor Activity

Timothy L. Ratliff, Daniel Gillen, William J. Catàlona · The Journal of Urology · 1987 · 233 citations

Life Sciences, Immunology, Oncology +15

Regression of bladder tumors in mice treated with interleukin 2 gene-modified tumor cells.

James R. Connor, Rajat Bannerji, Shigeru Saito et al. · The Journal of Experimental Medicine · 1993 · 208 citations · Full text

Medicine, Immunology, Oncology +17

Induction of urinary interleukin-1 (IL-1), IL-2, IL-6, and tumour necrosis factor during intravesical immunotherapy with bacillus Calmette-Guérin in superficial bladder cancer

Elizabeth C. de Boer, Wim H. de Jong, P. A. Steerenberg et al. · Cancer Immunology Immunotherapy · 1992 · 201 citations · Full text

Medicine, Immunology, Urology +14